Zinc-Manganese Sulfide Nanoplatform for Tumor-Microenvironment-Responsive Chemodynamic/Gas Therapy and Immunomodulation | Synapse
March 22, 2026
Zinc-Manganese Sulfide Nanoplatform for Tumor-Microenvironment-Responsive Chemodynamic/Gas Therapy and Immunomodulation
Puntos clave
The goal is to enhance the effectiveness of chemodynamic therapy in cancer treatment using a zinc-manganese sulfide nanoplatform.
Developed a nanoplatform made of zinc-manganese sulfide.
Assessed the release of hydrogen peroxide in the tumor microenvironment.
Evaluated the immunomodulatory effects of the nanoplatform.
Demonstrated improved hydrogen peroxide generation in solid tumors.
Increased cell death in tumor models compared to standard chemodynamic therapy.
Enhanced immune response against tumor cells.
Resumen
Chemodynamic therapy (CDT) holds promise for cancer treatment, yet its efficacy is often limited by insufficient hydrogen peroxide (H2O2) supply and the dense extracellular matrix (ECM) in solid tumors. To...